Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/25 07:58:21 am
132.6 EUR   +1.14%
01/21CARL ZEISS MEDITEC AG : DZ Bank drops its Sell rating
MD
01/20CARL ZEISS MEDITEC AG : Berenberg sticks Neutral
MD
01/20CARL ZEISS MEDITEC AG : Deutsche Bank reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
  • The tendency within the weekly time frame is positive above the technical support level at 102.4 EUR
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at EUR 140.22.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 65.42 and 56.71 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
CARL ZEISS MEDITEC AG20.39%14 273
THERMO FISHER SCIENTIFIC10.48%203 954
DANAHER CORPORATION7.16%169 098
SHENZHEN MINDRAY BIO-MEDICA..12.25%89 689
INTUITIVE SURGICAL, INC.-9.05%87 471
ILLUMINA, INC.9.80%59 313
SIEMENS HEALTHINEERS AG6.55%58 301
EDWARDS LIFESCIENCES CORPOR..-6.26%53 300
BOSTON SCIENTIFIC CORPORATI..3.00%53 024
KONINKLIJKE PHILIPS N.V.4.24%50 522
AGILENT TECHNOLOGIES, INC.6.62%38 764
RESMED, INC.1.39%31 232
OLYMPUS CORPORATION-6.91%26 018
CERNER CORPORATION1.81%24 497
HOLOGIC, INC.3.94%19 505
PERKINELMER, INC.5.86%17 010
More Results
Financials
Sales 2021 1 507 M 1 831 M 1 831 M
Net income 2021 182 M 221 M 221 M
Net cash 2021 612 M 744 M 744 M
P/E ratio 2021 65,4x
Yield 2021 0,51%
Capitalization 11 726 M 14 273 M 14 246 M
EV / Sales 2021 7,37x
EV / Sales 2022 6,62x
Nbr of Employees 3 290
Free-Float 40,9%
Upcoming event on CARL ZEISS MEDITEC AG
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes